Department of Health and Human Services July 19, 2005 – Federal Register Recent Federal Regulation Documents

Food Labeling; Gluten-Free Labeling of Foods; Public Meeting; Request for Comments
Document Number: 05-14196
Type: Proposed Rule
Date: 2005-07-19
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA) is announcing a public meeting to obtain expert comment and consultation from stakeholders to help the agency to define and permit the voluntary use on food labeling of the term ``gluten-free''. The meeting will focus on food manufacturing, analytical methods, and consumer issues related to reduced levels of gluten in food. We request that those who wish to speak at the meeting, or otherwise provide FDA with their written or oral comments, focus on the questions set out in this document.
Notice of Meeting
Document Number: 05-14183
Type: Notice
Date: 2005-07-19
Agency: Agency for Healthcare Research and Quality, Department of Health and Human Services
Notice of Meeting
Document Number: 05-14182
Type: Notice
Date: 2005-07-19
Agency: Department of Health and Human Services, Agency for Healthcare Research and Quality
Single Gene Disorders Resource Network
Document Number: 05-14166
Type: Notice
Date: 2005-07-19
Agency: Centers for Disease Control and Prevention, Department of Health and Human Services
Notice of SAMHSA's Anticipated FY 2006 Grant Funding Opportunities
Document Number: 05-14163
Type: Notice
Date: 2005-07-19
Agency: Department of Health and Human Services, Substance Abuse and Mental Health Services Administration
This notice is to inform the public of SAMHSA's anticipated grant funding opportunities for FY 2006, based on the President's FY 2006 budget request. All information provided is tentative and preliminary. These plans may change and final figures will not be available until after SAMHSA receives its 2006 appropriation. In January 2005, SAMHSA ceased publishing notices of grant funding opportunities in the Federal Register, consistent with the Department of Health and Human Services management objectives. Announcements are instead posted on http://www.Grants.gov and on SAMHSA's Web site at http://www.samhsa.gov. Interested applicants should visit these Web sites for specific information about these programs as it becomes available. Applicants should also be aware that all the necessary information to apply for grant funds will continue to be available at SAMHSA's two national clearinghouses: the National Clearinghouse for Alcohol and Drug Information (NCADI)-1-800-729-6686for substance abuse prevention or treatment grants; and the National Mental Health Information Center-1-800-789-CMHS (2647)for mental health grants.
Meetings: Disease, Disability, and Injury Prevention and Control Special Emphasis Panel
Document Number: 05-14162
Type: Notice
Date: 2005-07-19
Agency: Centers for Disease Control and Prevention, Department of Health and Human Services
Center for Mental Health Services; Notice of Meeting
Document Number: 05-14157
Type: Notice
Date: 2005-07-19
Agency: Department of Health and Human Services, Substance Abuse and Mental Health Services Administration
Guidance for Industry on Dispute Resolution Procedures for Science-Based Decisions on Products Regulated by the Center for Veterinary Medicine; Availability
Document Number: 05-14137
Type: Notice
Date: 2005-07-19
Agency: Food and Drug Administration, Department of Health and Human Services
The Food and Drug Administration (FDA) is announcing the availability of a guidance for industry (79) entitled ``Guidance for Industry: Dispute Resolution Procedures for Science- Based Decisions on Products Regulated by the Center for Veterinary Medicine (CVM).'' This guidance document describes dispute resolution procedures by which sponsors, applicants, or manufacturers of FDA- regulated products for animals may request review of science-based decisions. This guidance does not address procedures for handling issues associated with FDA's new initiative to enhance pharmaceutical good manufacturing practices (GMPs).